Quarterly Call Option Transactions in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during . The information is specifically focused on institutions that hold call options of IOVANCE BIOTHERAPEUTICS, INC..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 611,000 | 73,356 | 684,356 | 1,814,100 | 1,300,000 | 3,114,100 | -2,429,744 | |
| Q4 2021 | 1,460,900 | 561,700 | 2,022,600 | 142,200 | 73,000 | 215,200 | 1,807,400 | |
| Q1 2022 | 337,400 | 310 | 337,710 | 1,125,800 | 1,171,500 | 2,297,300 | -1,959,590 | |
| Q2 2022 | 476,500 | 193,900 | 670,400 | 829,400 | 100 | 829,500 | -159,100 | |
| Q3 2022 | 299,900 | 186,200 | 486,100 | 385,200 | 0 | 385,200 | 100,900 | |
| Q4 2022 | 10,700 | 82,600 | 93,300 | 843,000 | 0 | 843,000 | -749,700 | |
| Q1 2023 | 260,300 | 220,000 | 480,300 | — | 480,300 | |||
| Q2 2023 | 225,200 | 76,300 | 301,500 | 70,900 | 0 | 70,900 | 230,600 | |
| Q3 2023 | 1,320,400 | 3,698,400 | 5,018,800 | 22,800 | 0 | 22,800 | 4,996,000 | |
| Q4 2023 | 1,494,700 | 212,300 | 1,707,000 | 70,800 | 0 | 70,800 | 1,636,200 | |
| Q1 2024 | 1,137,800 | 299,800 | 1,437,600 | 2,418,900 | 0 | 2,418,900 | -981,300 | |
| Q2 2024 | 0 | 50,000 | 50,000 | 1,667,400 | 0 | 1,667,400 | -1,617,400 | |
| Q3 2024 | 192,100 | 2,509,500 | 2,701,600 | 41,300 | 0 | 41,300 | 2,660,300 | |